Pachyonychia congenita with corneal dystrophy | Zendy

Guo Hong | Zendy; Liu Dan | Zendy; Wu Jun | Zendy; Liao Qiong | Zendy; Bai Yun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Pachyonychia congenita with corneal dystrophy

Author(s) -

Guo Hong,

Liu Dan,

Wu Jun,

Liao Qiong,

Bai Yun

Publication year - 2013

Publication title -

the journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.9

H-Index - 65

eISSN - 1346-8138

pISSN - 0385-2407

DOI - 10.1111/1346-8138.12183

Subject(s) - china , medical genetics , medical school , medicine , corneal dystrophy , family medicine , medical science , ophthalmology , library science , medical education , history , genetics , biology , cornea , archaeology , computer science , gene

label, phase III study. Lancet Oncol 2009; 10: 223–232. 2 Santini V, Fenaux P, Mufti GJ et al. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine. Eur J Haematol 2010; 85: 130–138. 3 Fandy TE, Carraway H, Gore SD. DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies. Cancer J 2007; 13: 40–48. 4 Almeida AM, Pierdomenico F. Generalized skin reactions in patients with MDS and CMML treated with azacitidine: effective management with concomitant prednisolone. Leuk Res 2012; 36: e211–e213. 5 Tintle S, Patel V, Ruskin A et al. Azacitidine: a new medication associated with Sweet syndrome. J Am Acad Dermatol 2011; 64: e77– e79.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research